A study to evaluate the safety of stopping versus continuing anti TNF therapy in ulcerative colitis patients in remission, and to evaluate the safety and efficacy of restarting anti TNF therapy in patients with disease recurrence A study to evaluate the safety of stopping versus continuing anti TNF therapy in ulcerative colitis ...
A prospective, open randomized, parallel-group study to evaluate the outcome of discontinuing or continuing anti-tumor necrosis factor treatment in patients with ulcerative colitis in sustained clinical remission. - The Biostop study A prospective, open randomized, parallel-group study to evaluate the outcome of discontinuing or con ...